Heart Failure with Preserved Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Preserved Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Tailored Exercise Training Study Among Adults With HFpEF [Phase 2, Phase 3]
A tailored exercise training study for adults with heart failure with preserved ejection fraction (HFpEF) is in Phase 2/Phase 3 and currentl…
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: A Preliminary Study for INFORMED [Phase 4]
Phase 4 clinical trial update for INFORMED, an ongoing study led by Weill Medical College of Cornell University, currently enrolling by invi…
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: Circulating RNAs in Acute Congestive Heart Failure
Massachusetts General Hospital is conducting a study on circulating RNAs as potential biomarkers in patients with acute decompensated heart …
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Inspiratory Muscle Training in HFpEF [NA]
A Mayo Clinic-sponsored clinical trial is evaluating inspiratory muscle training for heart failure with preserved ejection fraction and is c…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: US Benchmarking Clinical Study
Sponsor eMyosound SAS reports that the US benchmarking clinical study is currently recruiting participants for conditions including heart fa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Enhancing the Natriuretic Peptide System in HFpEF [Phase 1, Phase 2]
This is a Phase 1/Phase 2 clinical trial updating on strategies to enhance the natriuretic peptide system in heart failure with preserved ej…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction [Phase 2, Phase 3]
An ongoing randomized controlled trial is evaluating a low-energy diet to improve functional status in heart failure with preserved ejection…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation [Phase 2]
Phase 2 trial of dapagliflozin in patients with failing Fontan circulation is currently recruiting. The study also considers effects in sing…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Characteristics, Phenotypes, and TRAITS of Heart Failure With Preserved Ejection Fraction (TRAITS-HFpEF)
This entry describes a recruiting clinical study evaluating characteristics, phenotypes, and traits of heart failure with preserved ejection…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Development of Specific Diagnostic Tools for Cardiac Insufficiency With Preserved Ejection Fraction
A completed clinical trial assessing the development of diagnostic tools for heart failure with preserved ejection fraction (HFpEF).
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction [NA]
A recruiting trial evaluating discontinuation of beta-blockers in patients with heart failure and preserved ejection fraction.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure [Phase 2]
A Phase 2 study evaluating 68Ga-FAPI PET imaging to assess fibroblast activation in heart failure with preserved ejection fraction is curren…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Home-Based Cardiac Rehabilitation for Patients With Heart Failure [NA]
Vanderbilt University Medical Center is sponsoring a clinical trial evaluating home-based cardiac rehabilitation for patients with heart fai…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control [NA]
A clinical trial is currently recruiting to compare atrioventricular node ablation with conduction system pacing versus medical rate control…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction [NA]
A University of Pennsylvania–sponsored clinical trial is testing a behavioral economics–based program to motivate physical activity in patie…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia
AstraZeneca-sponsored clinical trial evaluating transthyretin amyloidosis cardiomyopathy in patients with heart failure with preserved eject…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Chronic Exogenous Ketosis in HFpEF [Phase 2]
Phase 2 study evaluating chronic exogenous ketosis in heart failure with preserved ejection fraction, currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction [Phase 4]
This is a Phase 4 clinical trial update evaluating epicardial adipose tissue composition in heart failure with preserved ejection fraction; …
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Sleep Extension to Improve Sleep Efficiency and QoL in HF With Preserved Ejection Fraction: the SLEEP-HF Pilot Study [NA]
A completed pilot clinical trial evaluating whether extending sleep duration improves sleep efficiency and quality of life in patients with …
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction [Phase 1]
A Phase 1 study of HS135 in obese patients with heart failure with preserved ejection fraction and pulmonary hypertension was terminated.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition [NA]
A recruiting clinical study evaluating how coronary microvascular dysfunction and body composition influence exercise capacity in patients w…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40% [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy and safety of AZD4831 in heart failure with preserved ejection fraction has completed, and the res…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants [Phase 4]
Phase 4 clinical trial update on pioglitazone for heart failure with preserved ejection fraction in adults with type 2 diabetes mellitus; th…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Study of JK07 in Patients With Chronic Heart Failure [Phase 2]
Phase 2 study update for JK07 in chronic heart failure; the trial (NCT06369298) is currently recruiting in patients with heart failure with …
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial [Phase 3]
Phase 3 SUMMIT trial evaluating tirzepatide in obesity and heart failure with preserved ejection fraction has completed; results were posted…